Back to search

Article

Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults

2024-06-10

Abstract excerpt

<h4>Background</h4> Nicotinamide riboside (NR) is a promising compound for augmenting the intracellular NAD+ pool, potentially mitigating age-related decline and associated conditions. While oral NR supplementation has demonstrated safety and bioavailability in multiple animal and human studies, the effects of intravenous NR (NR IV) are far less understood. Until now, pharmaceutical grade NR was not available for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
442a41bc-42d0-5263-a1be-99de8bdc4ec8
DOI
10.1101/2024.06.06.24308565
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adultsDOI 10.1101/2024.06.06.24308565
Select a neighboring publication to make it the new centre.